Genes & biomarkers
PDGFRA variants
PDGFRA · exon 18 / D842V
In GIST, the exact variant, such as D842V, matters for drug selection.
Sources checked · Introductory guide
On this page
What does this result mean?
PDGFRA encodes a growth-signaling receptor. Point variants in some GIST differ from PDGFRA fusions found in certain blood disorders.[1]
How does it connect to treatment?
In the US, avapritinib is approved for adults with unresectable/metastatic GIST carrying PDGFRA exon 18 variants, including D842V. Not every PDGFRA alteration qualifies for the same drug.[2]
What should I check in my report?
Check D842V status, exon number and whether the finding is a point variant or fusion. The same gene name in another GIST patient does not establish the same drug choice.
Questions for your care team
- Does my PDGFRA result show D842V or another exon 18 variant?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- MedlinePlus Genetics · PDGFRA (opens in a new tab)
- NCI · Avapritinib for GIST with PDGFRA alteration (opens in a new tab)
- NCI · Avapritinib (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.